Sirtuin 1 inhibition: a promising avenue to suppress cancer progression through small inhibitors design.

Ullah, Atta; Waqas, Muhammad; Halim, Sobia Ahsan; Daud, Muhammad; Jan, Afnan; Khan, Ajmal; Al-Harrasi, Ahmed

Ullah, Atta; Waqas, Muhammad; Halim, Sobia Ahsan; Daud, Muhammad; Jan, Afnan; Khan, Ajmal; Al-Harrasi, Ahmed.

Afiliação

Ullah A; Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.
Waqas M; Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.
Halim SA; Department of Biotechnology and Genetic Engineering, Hazara University Mansehra, Dhodial, Pakistan.
Daud M; Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.
Jan A; Department of Zoology, Abdul Wali Khan University, Mardan, Pakistan.
Khan A; Faculty of Medicine, Department of Biochemistry, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Al-Harrasi A; Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.

J Biomol Struct Dyn ; : 1-17, 2023 Sep 03.

Article em En | MEDLINE | ID: mdl-37661778

Palavras-chave

SIRT1; cancer; molecular docking; molecular dynamic simulations; p53 protein

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Omã País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google